chr1-196737512-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000186.4(CFH):​c.2634C>T​(p.His878=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00975 in 1,612,918 control chromosomes in the GnomAD database, including 126 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 118 hom. )

Consequence

CFH
NM_000186.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.578
Variant links:
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 1-196737512-C-T is Benign according to our data. Variant chr1-196737512-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 294504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-196737512-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.578 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00867 (1319/152192) while in subpopulation SAS AF= 0.0222 (107/4820). AF 95% confidence interval is 0.0188. There are 8 homozygotes in gnomad4. There are 664 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CFHNM_000186.4 linkuse as main transcriptc.2634C>T p.His878= synonymous_variant 17/22 ENST00000367429.9 NP_000177.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CFHENST00000367429.9 linkuse as main transcriptc.2634C>T p.His878= synonymous_variant 17/221 NM_000186.4 ENSP00000356399 P2

Frequencies

GnomAD3 genomes
AF:
0.00865
AC:
1316
AN:
152074
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00625
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0102
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0224
Gnomad FIN
AF:
0.00756
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00984
Gnomad OTH
AF:
0.00957
GnomAD3 exomes
AF:
0.0104
AC:
2602
AN:
250892
Hom.:
24
AF XY:
0.0119
AC XY:
1617
AN XY:
135598
show subpopulations
Gnomad AFR exome
AF:
0.00518
Gnomad AMR exome
AF:
0.00608
Gnomad ASJ exome
AF:
0.00397
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0288
Gnomad FIN exome
AF:
0.00860
Gnomad NFE exome
AF:
0.0101
Gnomad OTH exome
AF:
0.00882
GnomAD4 exome
AF:
0.00986
AC:
14399
AN:
1460726
Hom.:
118
Cov.:
31
AF XY:
0.0108
AC XY:
7822
AN XY:
726684
show subpopulations
Gnomad4 AFR exome
AF:
0.00499
Gnomad4 AMR exome
AF:
0.00644
Gnomad4 ASJ exome
AF:
0.00464
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.0295
Gnomad4 FIN exome
AF:
0.00687
Gnomad4 NFE exome
AF:
0.00920
Gnomad4 OTH exome
AF:
0.00941
GnomAD4 genome
AF:
0.00867
AC:
1319
AN:
152192
Hom.:
8
Cov.:
32
AF XY:
0.00892
AC XY:
664
AN XY:
74404
show subpopulations
Gnomad4 AFR
AF:
0.00633
Gnomad4 AMR
AF:
0.0102
Gnomad4 ASJ
AF:
0.00490
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0222
Gnomad4 FIN
AF:
0.00756
Gnomad4 NFE
AF:
0.00984
Gnomad4 OTH
AF:
0.00947
Alfa
AF:
0.0116
Hom.:
25
Bravo
AF:
0.00800
Asia WGS
AF:
0.0130
AC:
44
AN:
3478
EpiCase
AF:
0.0125
EpiControl
AF:
0.0130

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 10, 2017- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024CFH: BP4, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hemolytic uremic syndrome, atypical, susceptibility to, 1 Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Basal laminar drusen Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Age related macular degeneration 4 Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Factor H deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Atypical hemolytic-uremic syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenSep 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.6
DANN
Benign
0.41
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35292876; hg19: chr1-196706642; COSMIC: COSV66405515; API